Linee guida e PDTA

88 LINEE GUIDA E PDTA 56. World Health Organization (WHO). Operational considerations for case management of COVID-19 in health facility and community. 2020: https://www.who.int/publications/i/item/ operational-considerations-for-case-management-of-covid- 19-in-health-facility-and-community (Accessed 01/12/2021). 57. Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS). Portale Covid-19. 2021: https://www.agenas.gov.it/covid19/ web/index.php?r=site%2Fresilienza (Accessed 01/12/2021). 58. Governo Italiano - Presidenza del Consiglio dei Ministri. Coronavi- rus, le misure adottate dal Governo. 2021: https://www.governo. it/it/coronavirus-misure-del-governo (Accessed 01/12/2021). 59. Patriti A, Baiocchi GL, Catena F, Marini P, Catarci M. Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life. World J Emerg Surg 2020; 15(1):36. 60. Decreto Ministeriale 2 aprile 2015, n. 70. Regolamento recan- te definizione degli standard qualitativi, strutturali, tecnolo- gici e quantitativi relativi all’assistenza ospedaliera. G.U. del 4 giugno 2015, n. 127. 61. Groene O, Kringos D, Sunol R, on behalf of the DUQuE Project. Seven ways to improve quality and safety in hospitals. An evidence-based guide. DUQuE Collaboration, 2014. 62. Seys D, Bruyneel L, Deneckere S, et al. Better organized care via care pathways: a multicenter study. PloS One 2017; 12(7):e0180398. 63. Rotter T, Kinsman L, James E, et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and ho- spital costs. Cochrane Database Syst Rev 2010; (3):CD006632. 64. Conferenza Stato-Regioni. Repertorio atto n. 59/CSR - Seduta del 17/04/2019. 65. National Research Council Committee. A framework for deve- loping a new taxonomy of disease. The National Academies Collection: Reports funded by National Institutes of Health. Toward Precision Medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washing- ton (DC): National Academies Press (US), 2011.

BIBLIOGRAFIA 89 66. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996; 312(7023):71-2. 67. Tinetti ME, Bogardus ST, Jr., Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple condi- tions. N Engl J Med 2004; 351(27):2870-4. 68. Paraskevas KI, de Borst GJ, Veith FJ. Why randomized control- led trials do not always reflect reality. J Vascular Surg 2019; 70(2):607-14.e3. 69. Kuhn T. The structure of scientific revolutions. Chicago: The University of Chicago Press, 1970. 70. Hood L, Balling R, Auffray C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnology J 2012; 7(8):992-1001. 71. Schork NJ. Personalized medicine: time for one-person trials. Nature 2015; 520(7549):609-11. 72. National Center for Health Statistics (NCHS), Centers for Medicare & Medicaid Services (CMS). The International Classi- fication of Diseases, 9th Revision, Clinical Modification (ICD- 9-CM), Sixth Edition. 2008: http://icd9.chrisendres.com/ (Accessed 13/12/2021). 73. World Health Organization (WHO). ICD-11 - International Classification of Diseases 11th Revision. 2021: https://icd. who.int/en (Accessed 13/12/2021). 74. UpToDate. Wolters Kluwer, 2021: https://www.uptodate.com/ contents/search (Accessed 13/12/2021). 75. Clinical Key. Elsevier, 2021: www.clinicalkey.com (Accessed 13/12/2021). 76. SPREAD – Stroke Prevention and Educational Awareness Diffu- sion. Ictus cerebrale: Linee guida italiane di prevenzione e trat- tamento. Raccomandazioni e sintesi. Stesura del 21 luglio 2016. 77. National Library of Medicine (NLM). Medical Subject Headings: https://www.nlm.nih.gov/mesh/meshhome.html (Accessed 14/03/2019).

90 LINEE GUIDA E PDTA 78. World Health Organization (WHO). ATC/DDD Index 202: https:// www.whocc.no/atc_ddd_index/ (Accessed 13/12/2021). 79. SNOMED International. SNOMED-CT (Systematized Nomen- clature of Human and Veterinary Medicine - Clinical Terms). 2021: https://www.snomed.org/ (Accessed 13/12/2021). 80. Köhler S, Gargano M, Matentzoglu N, et al. The human pheno- type ontology in 2021. Nucleic Acids Res 2021; 49(D1):D1207- D1217. 81. Itchhaporia D. Navigating the path to digital transformation. J Am Coll Cardiol 2021; 78(4):412-4. 82. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nature Med 2019; 25(1):44- 56. 83. Dorsey ER, Topol EJ. Telemedicine 2020 and the next decade. Lancet 2020; 395(10227):859. 84. Bachtiger P, Plymen CM, Pabari PA, et al. Artificial intelligen- ce, data sensors and interconnectivity: future opportunities for heart failure. Cardiac Failure Rev 2020; 6:e11. 85. Barrett M, Boyne J, Brandts J, et al. Artificial intelligence sup- ported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care. EPMA J 2019; 10(4):445-64. 86. Meskó B. The real era of the art of medicine begins with arti- ficial intelligence. J Med Internet Res 2019; 21(11):e16295. 87. Bhavnani SP, Parakh K, Atreja A, et al. 2017 Roadmap for Innovation-ACC Health Policy Statement on healthcare tran- sformation in the era of digital health, big data, and precision health: a report of the American College of Cardiology Task Force on Health Policy Statements and Systems of Care. J Am Coll Cardiol 2017; 70(21):2696-718.

Finito di stampare nel mese di maggio 2022 da Ti Printing S.r.l. Via delle Case Rosse 23, 00131 Roma co Editore, Romafiper conto de Il Pensiero Scienti